Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series
CONCLUSION: Cases of SLE associated with COVID-19 vaccination against are infrequent. However, clinical monitoring is recommended for persons receiving the SARS-CoV-2 vaccine, mainly those receiving the first dose and the Pfizer-BioNTech-162b2 vaccine.PMID:38315894 | DOI:10.1177/09612033241232054
Source: Lupus - Category: Rheumatology Authors: Nelson Luis Cahuapaza-Gutierrez Source Type: research
More News: AstraZeneca | Covid Vaccine | COVID-19 | Databases & Libraries | Lupus | Pfizer | Rheumatology | SARS | Science | Statistics | Study | Vaccines